Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kiyoshi Minegishi"'
Autor:
Takahiro Kanbe, Kiyoshi Minegishi, Hiromi Sato, Koji Okazaki, Mitsutoshi Matsuda, Kumi Obara, Shoichi Inaba, Hiroyuki Igarashi, Takayuki Enomoto
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 64:525-528
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9f59851356bbdc273cf4c629d631d74
https://doi.org/10.3925/jjtc.64.525
https://doi.org/10.3925/jjtc.64.525
Autor:
Yukihiro Oryu, Taku Nonomura, Masafumi Takeyama, Atsushi Komuro, Kento Suzuki, Sagar Bhandari, Motofumi Tanaka, Kiyoshi Minegishi, Noritsugu Kubo, Nobuyoshi Watanabe, Hirokazu Kawabata, Hideaki Sato
Publikováno v:
The Proceedings of Mechanical Engineering Congress, Japan. 2019:S05214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd5ffd5f47237a6b0cf919e1d3166696
https://doi.org/10.1299/jsmemecj.2019.s05214
https://doi.org/10.1299/jsmemecj.2019.s05214
Autor:
Keiko Miyakawa, Akira Yoshikawa, Kiyoshi Minegishi, Hideaki Mizoguchi, Rikizo Taira, Katsumi Tachibana, Yuko Gotanda, Kenji Tadokoro, Satoru Hino, H Ohnuma
Publikováno v:
Transfusion. 47:1162-1171
BACKGROUND: The Japanese Red Cross (JRC) implemented a fully automated pooling and nucleic acid amplification test (NAT) system for testing seronegative donations. The JRC sample repository and repeat blood donations allowed for lookback and follow-u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a442aff26b57924a98485b1299cf8b2d
https://doi.org/10.1111/j.1537-2995.2007.01234.x
https://doi.org/10.1111/j.1537-2995.2007.01234.x
Autor:
Kusuya Nishioka, Akira Yoshikawa, Kimihiro Kanemitsu, Masako Itabashi, Yuhko Gotanda, Kiyoshi Minegishi
Publikováno v:
Vox Sanguinis. 88:77-86
Background and Objectives The Japanese Red Cross (JRC) carries out nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus-1 (HIV-1) by using a multiplex (MPX) reagent. Screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cd0e6009f47620b9b46cdc7a0f3314a
https://doi.org/10.1111/j.1423-0410.2005.00602.x
https://doi.org/10.1111/j.1423-0410.2005.00602.x
Autor:
Hiroyuki Emura, Hiroyuki Murokawa, Kiyoshi Minegishi, Akira Yoshikawa, Retsuji Yamanaka, Kusuya Nishioka, Hideko Mine, Tsugikazu Tomono, Masaki Miyamoto
Publikováno v:
Journal of Virological Methods. 112:145-151
Nationwide nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) of blood donated voluntarily after serological screening was implemented on July 1st 1999 for tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d70d26caa05615d107f2234fc64c47
https://doi.org/10.1016/s0166-0934(03)00215-5
https://doi.org/10.1016/s0166-0934(03)00215-5
Autor:
Tsugikazu Tomono, Shigeki Yokoyama, Toru Hirose, Masaki Miyamoto, H Ohnuma, Takeshi Tanaka, Kusuya Nishioka, Hideko Mine, Kiyoshi Minegishi, Akira Yoshikawa, Yoshio Takeda, Retsuji Yamanaka, Yasushi Doi, Takashi Murozuka, Seiji Nakahira, Hisao Yugi Lizuka, Hiroyuki Murokawa, Shuhei Satoh
Publikováno v:
Microbiology and Immunology. 45:667-672
The first nationwide nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1) of voluntarily donated blood after serological pre-screening and before release of cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b7e61059b31698085da1fd7f380a40
https://doi.org/10.1111/j.1348-0421.2001.tb01300.x
https://doi.org/10.1111/j.1348-0421.2001.tb01300.x
Autor:
Akira, Yoshikawa, Yuhko, Gotanda, Masako, Itabashi, Kiyoshi, Minegishi, Kimihiro, Kanemitsu, Kusuya, Nishioka
Publikováno v:
Vox sanguinis. 88(2)
The Japanese Red Cross (JRC) carries out nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus-1 (HIV-1) by using a multiplex (MPX) reagent. Screening is undertaken on serologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::79aa325527208822b4f4938b62858acd
https://pubmed.ncbi.nlm.nih.gov/15720604
https://pubmed.ncbi.nlm.nih.gov/15720604
Autor:
Kusuya Nishioka, H. Yugi, H. Kiyokawa, Akira Yoshikawa, M. Sakurada, Kiyoshi Minegishi, S. Kishimoto, N. Yokoya
Publikováno v:
Vox sanguinis. 84(4)
Background and Objectives The Japanese Red Cross (JRC) have developed a fully automated multiplex (MPX) nucleic acid amplification technology (NAT) system for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus 1 (HIV-1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69d635b57f4b468b10929a448047c31
https://pubmed.ncbi.nlm.nih.gov/12757502
https://pubmed.ncbi.nlm.nih.gov/12757502
Autor:
Michael Houghton, Kiyoshi Minegishi, Tomoko Mitsumori, Seiichi Furuta, Makiko Ishifuji, Eiichi Tokunaga, Kusuya Nishioka, Qui-Lim Choo, Tohru Katayama, George Kuo, Masahiro Ueda, Takashi Oguchi, Kendo Kiyosawa, Eiji Tanaka, Junnosuke Watanabe
Publikováno v:
Vox Sanguinis. 59:86-88
Prospective studies of posttransfusion hepatitis carried out in the past decade showed that 18.1% of the blood transfusions resulted in non-A non-B hepatitis in Japan. As an approach to the prevention of posttransfusion non-A non-B hepatitis (PTNANB)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93b49d1faa5640112868f2d69afb331
https://doi.org/10.1111/j.1423-0410.1990.tb05015.x
https://doi.org/10.1111/j.1423-0410.1990.tb05015.x